PAK2 and chronic myelogenous leukemia, BCR-ABL1 positive: In the majority of cell lines other than CML-T1, we observed a decrease for Ser141 phosphorylation status but not for the total PAK2 level after 2 h treatment with IPA-3 (Figure 6C and Figure S7).